Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema C Haritoglou, D Kook, A Neubauer, A Wolf, S Priglinger, R Strauss, ... Retina 26 (9), 999-1005, 2006 | 684 | 2006 |
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 247 | 2022 |
Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival CS Alge, SM Hauck, SG Priglinger, A Kampik, M Ueffing Journal of proteome research 5 (4), 862-878, 2006 | 204 | 2006 |
Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study Y Ogura, J Roider, JF Korobelnik, FG Holz, C Simader, U Schmidt-Erfurth, ... American journal of ophthalmology 158 (5), 1032-1038. e2, 2014 | 189 | 2014 |
The protective effect of quercetin against oxidative stress in the human RPE in vitro D Kook, AH Wolf, LY Alice, AS Neubauer, SG Priglinger, A Kampik, ... Investigative ophthalmology & visual science 49 (4), 1712-1720, 2008 | 177 | 2008 |
Retinal pigment epithelium is protected against apoptosis by αB-crystallin CS Alge, SG Priglinger, AS Neubauer, A Kampik, M Zillig, H Bloemendal, ... Investigative ophthalmology & visual science 43 (11), 3575-3582, 2002 | 176 | 2002 |
An in vivo evaluation of Brilliant Blue G in animals and humans M Remy, S Thaler, RG Schumann, CA May, M Fiedorowicz, F Schuettauf, ... British Journal of Ophthalmology 92 (8), 1142-1147, 2008 | 165 | 2008 |
Multicenter study of descemet membrane endothelial keratoplasty: first case series of 18 surgeons C Monnereau, R Quilendrino, I Dapena, VS Liarakos, JF Alfonso, ... JAMA ophthalmology 132 (10), 1192-1198, 2014 | 154 | 2014 |
Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial SG Priglinger, AH Wolf, TC Kreutzer, D Kook, A Hofer, RW Strauss, ... Retina 27 (8), 1004-1012, 2007 | 154 | 2007 |
Five-year follow-up of macular hole surgery with peeling of the internal limiting membrane: update of a prospective study C Haritoglou, IW Reiniger, M Schaumberger, CA Gass, SG Priglinger, ... Retina 26 (6), 618-622, 2006 | 149 | 2006 |
Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells CS Alge, S Suppmann, SG Priglinger, AS Neubauer, CA May, S Hauck, ... Investigative ophthalmology & visual science 44 (8), 3629-3641, 2003 | 144 | 2003 |
Compliance and adherence of patients with diabetic macular edema to intravitreal anti–vascular endothelial growth factor therapy in daily practice M Weiss, DA Sim, T Herold, RG Schumann, R Liegl, C Kern, T Kreutzer, ... Retina 38 (12), 2293-2300, 2018 | 135 | 2018 |
Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion TC Kreutzer, CS Alge, AH Wolf, D Kook, J Burger, R Strauß, C Kunze, ... British Journal of Ophthalmology 92 (3), 351-355, 2008 | 135 | 2008 |
Functional outcome after trypan blue–assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial C Haritoglou, K Eibl, M Schaumberger, AJ Mueller, S Priglinger, C Alge, ... American journal of ophthalmology 138 (1), 1-5, 2004 | 135 | 2004 |
Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset NJ Newman, P Yu-Wai-Man, V Carelli, ML Moster, V Biousse, ... Ophthalmology 128 (5), 649-660, 2021 | 126 | 2021 |
Comparison of foveal thickness measured with the retinal thickness analyzer and optical coherence tomography AS Neubauer, S Priglinger, S Ullrich, M Bechmann, MJ Thiel, MW Ulbig, ... Retina 21 (6), 596-601, 2001 | 124 | 2001 |
Trypan blue in macular pucker surgery: an evaluation of histology and functional outcome C Haritoglou, A Gandorfer, M Schaumberger, SG Priglinger, AJ Mueller, ... Retina 24 (4), 582-590, 2004 | 115 | 2004 |
Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap) AS Neubauer, M Kernt, C Haritoglou, SG Priglinger, A Kampik, MW Ulbig Graefe's Archive for Clinical and Experimental Ophthalmology 246, 229-235, 2008 | 106 | 2008 |
Individualized stabilization criteria–driven ranibizumab versus laser in branch retinal vein occlusion: six-month results of BRIGHTER R Tadayoni, SM Waldstein, F Boscia, H Gerding, I Pearce, S Priglinger, ... Ophthalmology 123 (6), 1332-1344, 2016 | 104 | 2016 |
Individualized ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve-month results of the CRYSTAL study M Larsen, SM Waldstein, F Boscia, H Gerding, J Monés, R Tadayoni, ... Ophthalmology 123 (5), 1101-1111, 2016 | 102 | 2016 |